CBD may protect against psychiatric risk from high-THC cannabis strains

Did you know that? 12 September 2017 | 0 Comments

A study by neuroscientists finds that a non-psychoactive compound in cannabis called cannabidiol, or CBD, appears to protect against the long-term negative psychiatric effects of THC, the primary psychoactive ingredient in cannabis.

Tagged in ,

FDA Seeking Public Comments On CBD

Generic 30 August 2017 | 0 Comments

On Regulations.Gov, right now, the Federal Food and Drug Administration (FDA) is soliciting public comments with regard to the therapeutic utility and abuse liability of various controlled substances, including cannabidiol (CBD). The agency will consider these comments prior to preparing a formal response to the World Health Organization, which is considering placing the substances within their [...]

Tagged in , ,

DEA Reaffirms Stance That CBD Meets Schedule I Criteria — Reality Says Otherwise

Generic 11 July 2017 | 0 Comments

The US Drug Enforcement Administration has publicly reiterated its position that cannabidiol, a non-psychotropic cannabinoid, is properly categorized under federal law as a schedule I controlled substance — meaning that, by definition, it possesses “a high potential for abuse,” “no currently accepted medical use in treatment in the United States,” and lacks “accepted safety … [...]

Tagged in , , ,

Study: Cannabinoids Reduce Migraine Frequency

Generic 6 July 2017 | 0 Comments

The prolonged daily administration of cannabinoids is associated with a reduction in migraine headache frequency, according to clinical trial data presented at the 3rd Congress of the European Academy of Neurology. Italian researchers compared the efficacy of oral cannabinoid treatments versus amitriptyline – a depressant commonly prescribed for migraines – in 79 chronic migraine patients [...]

Tagged in ,

Study: CBD Administration Reduces Blood Pressure

Generic 21 June 2017 | 0 Comments

Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation. Investigators from the University of Nottingham in the United Kingdom assessed the effects of a single oral dose of 600 mg of CBD extract versus placebo in nine male subjects. [...]

Tagged in , ,